These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19603143)

  • 1. An in vitro study, evaluating the effect of sunitinib and/or lapatinib on two glioma cell lines.
    Giannopoulou E; Dimitropoulos K; Argyriou AA; Koutras AK; Dimitrakopoulos F; Kalofonos HP
    Invest New Drugs; 2010 Oct; 28(5):554-60. PubMed ID: 19603143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of anti-VEGFR and anti-EGFR agents on glioma cell migration through implication of growth factors with integrins.
    Dimitropoulos K; Giannopoulou E; Argyriou AA; Zolota V; Petsas T; Tsiata E; Kalofonos HP
    Anticancer Res; 2010 Dec; 30(12):4987-92. PubMed ID: 21187479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Berberine enhances inhibition of glioma tumor cell migration and invasiveness mediated by arsenic trioxide.
    Lin TH; Kuo HC; Chou FP; Lu FJ
    BMC Cancer; 2008 Feb; 8():58. PubMed ID: 18294404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fucoxanthin Activates Apoptosis via Inhibition of PI3K/Akt/mTOR Pathway and Suppresses Invasion and Migration by Restriction of p38-MMP-2/9 Pathway in Human Glioblastoma Cells.
    Liu Y; Zheng J; Zhang Y; Wang Z; Yang Y; Bai M; Dai Y
    Neurochem Res; 2016 Oct; 41(10):2728-2751. PubMed ID: 27394418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sunitinib can enhance BCG mediated cytotoxicity to transitional cell carcinoma through apoptosis pathway.
    Ping SY; Wu CL; Yu DS
    Urol Oncol; 2012 Sep; 30(5):652-9. PubMed ID: 20884251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous targeting of Src kinase and receptor tyrosine kinase results in synergistic inhibition of renal cell carcinoma proliferation and migration.
    Bai L; Yang JC; Ok JH; Mack PC; Kung HJ; Evans CP
    Int J Cancer; 2012 Jun; 130(11):2693-702. PubMed ID: 21792888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyrosine kinase receptor inhibitor-targeted combined chemotherapy for metastatic bladder cancer.
    Wu CL; Ping SY; Yu CP; Yu DS
    Kaohsiung J Med Sci; 2012 Apr; 28(4):194-203. PubMed ID: 22453067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic Effects of Ferula Latisecta on Human Glioma U87 Cells.
    Jalili-Nik M; Sabri H; Zamiri E; Soukhtanloo M; Roshan MK; Hosseini A; Mollazadeh H; Vahedi MM; Afshari AR; Mousavi SH
    Drug Res (Stuttg); 2019 Dec; 69(12):665-670. PubMed ID: 31499542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mangiferin regulates proliferation and apoptosis in glioma cells by induction of microRNA-15b and inhibition of MMP-9 expression.
    Xiao J; Liu L; Zhong Z; Xiao C; Zhang J
    Oncol Rep; 2015 Jun; 33(6):2815-20. PubMed ID: 25901555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sunitinib impedes brain tumor progression and reduces tumor-induced neurodegeneration in the microenvironment.
    Hatipoglu G; Hock SW; Weiss R; Fan Z; Sehm T; Ghoochani A; Buchfelder M; Savaskan NE; Eyüpoglu IY
    Cancer Sci; 2015 Feb; 106(2):160-70. PubMed ID: 25458015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical biology drug sensitivity screen identifies sunitinib as synergistic agent with disulfiram in prostate cancer cells.
    Ketola K; Kallioniemi O; Iljin K
    PLoS One; 2012; 7(12):e51470. PubMed ID: 23251544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early decline in serum phospho-CSE1L levels in vemurafenib/sunitinib-treated melanoma and sorafenib/lapatinib-treated colorectal tumor xenografts.
    Lee WR; Shen SC; Shih YH; Chou CL; Tseng JT; Chin SY; Liu KH; Chen YC; Jiang MC
    J Transl Med; 2015 Jun; 13():191. PubMed ID: 26070816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors: a Canadian Urologic Oncology Group/German Testicular Cancer Study Group cooperative study.
    Oechsle K; Honecker F; Cheng T; Mayer F; Czaykowski P; Winquist E; Wood L; Fenner M; Glaesener S; Hartmann JT; Chi K; Bokemeyer C; Kollmannsberger C
    Ann Oncol; 2011 Dec; 22(12):2654-2660. PubMed ID: 21415240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavior and anti-glioma effect of lapatinib-incorporated lipoprotein-like nanoparticles.
    Gao H; Yang Z; Cao S; Xi Z; Zhang S; Pang Z; Jiang X
    Nanotechnology; 2012 Nov; 23(43):435101. PubMed ID: 23060604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marchantin C: a potential anti-invasion agent in glioma cells.
    Shen J; Li G; Liu Q; He Q; Gu J; Shi Y; Lou H
    Cancer Biol Ther; 2010 Jan; 9(1):33-9. PubMed ID: 19923918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the cell death mechanisms of cytotoxic [1,2,3]triazolylcarborane lead compounds against U87 MG human glioblastoma cells.
    Alamón C; Dávila B; Cerecetto H; Couto M
    Chem Biol Drug Des; 2023 Jun; 101(6):1435-1445. PubMed ID: 36746676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of SL327 and Sunitinib Malate leads to an additive anti-cancer effect in doxorubicin resistant thyroid carcinoma cells.
    Wang W; Zhou J; Zhao L; Chen S
    Biomed Pharmacother; 2017 Apr; 88():985-990. PubMed ID: 28178630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoresponse assay for evaluating response to sunitinib in primary cultures of breast cancer.
    Suchy SL; Hancher LM; Wang D; Ervin PR; Brower SL
    Cancer Biol Ther; 2011 Jun; 11(12):1059-64. PubMed ID: 21525781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cell invasion by indomethacin on glioma cell lines: in vitro study.
    Wang M; Yoshida D; Liu S; Teramoto A
    J Neurooncol; 2005 Mar; 72(1):1-9. PubMed ID: 15803368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic cooperation between sunitinib and cisplatin promotes apoptotic cell death in human medullary thyroid cancer.
    Lopergolo A; Nicolini V; Favini E; Dal Bo L; Tortoreto M; Cominetti D; Folini M; Perego P; Castiglioni V; Scanziani E; Borrello MG; Zaffaroni N; Cassinelli G; Lanzi C
    J Clin Endocrinol Metab; 2014 Feb; 99(2):498-509. PubMed ID: 24276455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.